以上内容来自Benzinga Earnings专栏,原文如下:
Agilon Health (NYSE:AGL) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.23) by 13.04 percent. The company reported quarterly sales of $1.52 billion which met the analyst consensus estimate. This is a 43.94 percent increase over sales of $1.06 billion the same period last year.